Insecticides (India) Ltd FY26 Results: Revenue ₹2,140 Crore, PAT ₹139 Crore

Insecticides (India) Ltd announced its audited financial results for the fiscal year ending March 31, 2026. Consolidated revenue stood at ₹2,140.01 crore, with profit before tax (PBT) at ₹186.68 crore and profit after tax (PAT) at ₹139.41 crore.

Reader Takeaway: Solid FY26 financials and employee incentives announced; board reshuffle underway.

What just happened

The company reported its audited financial results for the fiscal year ended March 31, 2026. Consolidated revenue reached ₹2,140.01 crore, and consolidated PAT was ₹139.41 crore. On a standalone basis, revenue was ₹2,144.14 crore, with PAT at ₹135.82 crore. The company's auditors provided an unmodified opinion on these results.

Additionally, the board approved the formulation of the 'IIL ESPS Scheme 2026', covering up to 2,00,000 equity shares. In management changes, Mrs. Nikunj Aggarwal resigned as Whole Time Director, while Mr. Sanskar Aggarwal was appointed as a Whole Time Director (Additional).

Why this matters

The release of audited annual financials with an unmodified opinion offers clarity to investors on the company's financial health for FY26. The ESPS scheme signals a move to incentivize employees, potentially boosting morale and retention. Management changes can signal strategic shifts or transitions within the company.

The backstory

Insecticides (India) Ltd is a key player in the agrochemical sector, offering a wide range of products including insecticides, herbicides, and fungicides. The company has been focusing on expanding its product portfolio and market reach both domestically and internationally.

What changes now

With the financial year concluded and audited results published, the company has set its performance benchmark for FY26. The approved ESPS scheme will likely be implemented, impacting employee compensation structures. The new Whole Time Director will bring new perspectives to the board.

Risks to watch

While the audit opinion was unmodified, investors should monitor the integration of new management and the successful implementation of the ESPS scheme. The company also continues to monitor the finalization of rules for the New Labour Codes, though it estimates no incremental liability.

Peer comparison

Insecticides (India) Ltd operates in a competitive agrochemical landscape. Key competitors include UPL Ltd, Rallis India Ltd, and Bayer CropScience Ltd. Financial performance and strategic initiatives like employee stock options are crucial for maintaining market share.

Context metrics (time-bound)

• Consolidated Revenue (FY 2026): ₹2,140.01 crore
• Consolidated PAT (FY 2026): ₹139.41 crore
• Basic EPS (Consolidated, FY 2026): ₹47.91

What to track next

Investors will be keen to observe the company's performance in the current fiscal year, track the impact of the new Whole Time Director, and monitor any further updates regarding the ESPS scheme. The 29th Annual General Meeting on August 12, 2026, will be an important event for further disclosures.